Annual summary Institute for Cancer Research
Publications from Oslo University Hospital 2017 - 2025
Includes ordinary journal articles and reviews only.
| Name | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| OUS - Institute for Cancer Research | 209 | 153 | 218 | 203 | 237 | 195 | 150 | 173 | 95 |
| OUS - Department of Cancer Genetics | 47 | 32 | 41 | 47 | 53 | 51 | 29 | 47 | 21 |
| OUS - Breast tumor evolution (Sørlie) | 5 | 1 | 5 | 6 | 6 | 3 | 3 | 5 | 4 |
| OUS - Computational Systems Medicine (Aittokallio) | 3 | 5 | 5 | 7 | 16 | 22 | 13 | 15 | 5 |
| OUS - Molecular Genetic Studies of Breast and Ovarian Cancer (Russnes) | 34 | 17 | 28 | 21 | 20 | 14 | 6 | 14 | 8 |
| OUS - Translational studies in solid tumors (Helland) | 10 | 11 | 13 | 12 | 12 | 14 | 3 | 18 | 8 |
| OUS - Department of Cancer Immunology | 18 | 18 | 31 | 43 | 33 | 39 | 33 | 39 | 18 |
| OUS - Cell Signaling and Immune Regulation (Kjetil Taskén) | 0 | 3 | 9 | 4 | 9 | 10 | 10 | 8 | 7 |
| OUS - Experimental Immunotherapy (Olweus) | 5 | 2 | 3 | 4 | 6 | 7 | 5 | 4 | 3 |
| OUS - Immunomodulation and Targeted Therapies (Sioud) | 0 | 3 | 3 | 10 | 2 | 1 | 4 | 1 | 0 |
| OUS - Immunotherapy against solid cancers (Kyte) | 1 | 0 | 3 | 5 | 1 | 7 | 3 | 7 | 2 |
| OUS - Lymphoma biology group (Myklebust) | 8 | 4 | 4 | 8 | 9 | 2 | 3 | 6 | 2 |
| OUS - NK Cell Biology and Cell Therapy (Malmberg) | 5 | 6 | 4 | 10 | 5 | 10 | 7 | 12 | 3 |
| OUS - Department of Molecular Cell Biology | 35 | 22 | 30 | 38 | 47 | 42 | 40 | 20 | 19 |
| OUS - Autophagy (Simonsen) | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 3 |
| OUS - Cancer Molecular medicine (Enserink) | 5 | 2 | 2 | 2 | 7 | 3 | 9 | 4 | 1 |
| OUS - Cellular membrane dynamics (Stenmark) | 11 | 10 | 17 | 12 | 17 | 22 | 25 | 15 | 12 |
| OUS - Tumor-Host Biology (Rusten) | 3 | 1 | 4 | 7 | 4 | 4 | 1 | 0 | 2 |
| OUS - Department of Molecular Oncology (2006-2014 Dept of Cancer Prev.) | 27 | 19 | 22 | 11 | 18 | 11 | 6 | 13 | 6 |
| OUS - Epigenetics (Lind) | 5 | 3 | 2 | 4 | 2 | 4 | 2 | 3 | 1 |
| OUS - Genetics (Lothe) | 16 | 16 | 19 | 8 | 12 | 6 | 3 | 7 | 2 |
| OUS - Genome Biology Group (Skotheim) | 6 | 5 | 5 | 4 | 3 | 7 | 2 | 5 | 2 |
| OUS - Department of Radiation Biology | 35 | 26 | 30 | 35 | 27 | 21 | 19 | 18 | 10 |
| OUS - Clinical Radiation Biology | 4 | 5 | 4 | 2 | 2 | 4 | 2 | 7 | 2 |
| OUS - Photochemical Internalisation (PCI) | 15 | 8 | 8 | 18 | 13 | 14 | 9 | 4 | 7 |
| OUS - Radiation Biology and DNA Damage Signaling (Syljuåsen) | 6 | 6 | 10 | 7 | 6 | 5 | 5 | 5 | 0 |
| OUS - Department of Tumor Biology | 55 | 45 | 74 | 45 | 73 | 47 | 39 | 48 | 28 |
| OUS - Computational Cancer Genomics and Melanoma Systems Biology (Hovig) | 13 | 14 | 20 | 24 | 24 | 23 | 17 | 23 | 11 |
| OUS - Metastasis Biology and Experimental Therapeutics (Mælandsmo) | 14 | 7 | 21 | 12 | 24 | 15 | 10 | 10 | 6 |
| OUS - Molecular Biology of Sarcomas (Wesche) | 11 | 9 | 9 | 7 | 13 | 10 | 5 | 4 | 5 |
| OUS - Translational Cancer Therapy (Flatmark) | 16 | 10 | 22 | 8 | 12 | 8 | 9 | 8 | 3 |